Karyopharm Therapeutics develops and sells prescription medicines for cancer and other serious diseases. Its main services include drug discovery, clinical development, and commercial supply for patients, hospitals, and healthcare providers.
Karyopharm Therapeutics products and services overview:
Revenue: ~$140 million
Employees: 280
Headquarters: Newton, United States (USA)
Karyopharm Therapeutics is one of the...
Karyopharm Therapeutics is a company listed under the stock ticker KPTI (US).
Acquisition, funding and merger involving Karyopharm Therapeutics.
View the org chart displaying its 27 main executives
Create your alert
to follow the executive moves at Karyopharm Therapeutics.
Karyopharm Therapeutics has 1,919 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.